Literature DB >> 23808997

Increased regulatory T cells and impaired functions of circulating CD8 T lymphocytes is associated with viral persistence in Hepatitis B virus-positive newborns.

S Shrivastava1, N TrehanPati, S Patra, S Kottilil, C Pande, S S Trivedi, S K Sarin.   

Abstract

Hepatitis B Virus (HBV) infection in infancy or early childhood leads to high rate of persistent infection (25-90%). The immunological basis of high rate of viral persistence in vertically acquired HBV infections is not completely understood. CD8 T cells play a pivotal role in clearing the Hepatitis B virus infection in adults. Herein, we sought to delineate the role of T cells in viral persistence in HBsAg+ve newborns. At birth peripheral and cord blood of HBsAg+ve (N = 12), HBsAg-ve (N = 10) and healthy newborns (HC: N = 15) were evaluated for T-cell frequency and functionality by flow cytometry. No significant differences were observed in the frequency of CD8 and CD4 T cells in all the three groups. However, significantly higher frequency of FoxP3 expressing regulatory T cells were observed in HBsAg+ve (63.79%) compared with HBsAg-ve (28.12%) and HC (11.06%) (P < 0.05). Moreover, HBsAg+ve newborns showed functional defect in CD8 T cells by decreased IFN-γ production and lower CD107A expression (cytotoxic capacity) compared with HBsAg-ve and HC, which positively correlated with decreased TCRζ-chain expression CD8 T cells (r(2) > 0.93, P < 0.05). Despite equal frequency of CD8 T cells in all the three groups, CD8 T cells in HBsAg+ve newborns are dysfunctional. An expansion of regulatory T cells and impaired TCR signalling may represent the immune tolerant state of the adaptive immune system in response to chronic HBV infection.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  CD8 T-cell dysfunction; HBV-positive newborns; Peripheral Blood Mononuclear cells; T-cell function; T-cell receptor; regulatory T cells

Mesh:

Substances:

Year:  2013        PMID: 23808997     DOI: 10.1111/jvh.12078

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  13 in total

1.  Amphiregulin promotes the immunosuppressive activity of intrahepatic CD4+ regulatory T cells to impair CD8+ T-cell immunity against hepatitis B virus infection.

Authors:  Kai Dai; Ling Huang; Jing Chen; Lihua Yang; Zuojiong Gong
Journal:  Immunology       Date:  2015-03       Impact factor: 7.397

2.  Simultaneous or Prior Activation of Intrahepatic Type I Interferon Signaling Leads to Hepatitis B Virus Persistence in a Mouse Model.

Authors:  Shi Zou; Yanqin Du; Shunmei Huang; Shuilin Sun; Dongliang Yang; Jun Wu; Mingfa Chen; Xiaoli Yang; Sumeng Li; Yingshan Chen; Meihong Han; Jia Li; Qing Yu; Elisabeth Littwitz-Salomon; Hongming Huang; Mirko Trilling; Shi Liu; Rongjuan Pei; Jia Liu; Baoju Wang; Xin Zheng; Mengji Lu; Ulf Dittmer
Journal:  J Virol       Date:  2021-09-22       Impact factor: 5.103

3.  Manipulation of Regulatory Cells' Responses to Treatments for Chronic Hepatitis B Virus Infection.

Authors:  Soheil Tavakolpour; Seyed Moayed Alavian; Shahnaz Sali
Journal:  Hepat Mon       Date:  2016-05-25       Impact factor: 0.660

4.  Detection of Treg/Th17 cells and related cytokines in peripheral blood of chronic hepatitis B patients combined with thrombocytopenia and the clinical significance.

Authors:  Yinghui Wang; Liru Wang; Wei Gao; Xi Chen; Yanhua Su
Journal:  Exp Ther Med       Date:  2018-06-14       Impact factor: 2.447

Review 5.  Molecular Mechanisms to Control Post-Transplantation Hepatitis B Recurrence.

Authors:  Akinobu Takaki; Tetsuya Yasunaka; Takahito Yagi
Journal:  Int J Mol Sci       Date:  2015-07-30       Impact factor: 5.923

Review 6.  Contradictory immune response in post liver transplantation hepatitis B and C.

Authors:  Akinobu Takaki; Takahito Yagi; Kazuhide Yamamoto
Journal:  Int J Inflam       Date:  2014-08-24

7.  A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance.

Authors:  Thomas H King; Charles B Kemmler; Zhimin Guo; Derrick Mann; Yingnian Lu; Claire Coeshott; Adam J Gehring; Antonio Bertoletti; Zi Z Ho; William Delaney; Anuj Gaggar; G Mani Subramanian; John G McHutchison; Shikha Shrivastava; Yu-Jin L Lee; Shyamasundaran Kottilil; Donald Bellgrau; Timothy Rodell; David Apelian
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240

Review 8.  Regulatory T-cells promote hepatitis B virus infection and hepatocellular carcinoma progression.

Authors:  Wei Li; Jun Han; Hong Wu
Journal:  Chronic Dis Transl Med       Date:  2016-11-09

9.  Why the SARS-Cov-2 has prolonged spreading time in children?

Authors:  Sadık Yurttutan; Sevcan İpek; Utku U Güllü
Journal:  Pediatr Pulmonol       Date:  2020-05-01

10.  Clearance of HBeAg and HBsAg of HBV in mice model by a recombinant HBV vaccine combined with GM-CSF and IFN-α as an effective therapeutic vaccine adjuvant.

Authors:  Weidong Zhao; Gan Zhao; Shuren Zhang; Xianzheng Wang; Xueping Yu; Bin Wang
Journal:  Oncotarget       Date:  2018-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.